Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

ClinicalTrials.gov ID: NCT00672919

Public ClinicalTrials.gov record NCT00672919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-Arm, Open-Label, Multicenter Study Evaluating the Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia Following Treatment Conversion From Rosiglitazone to Pioglitazone HCl in Combination With Stable Statin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the triglyceride changes in subjects with type 2 diabetes mellitus taking pioglitazone, once daily (QD), following treatment conversion from rosiglitazone.

Study identification

NCT ID
NCT00672919
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Takeda
Industry
Enrollment
305 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2003 (Type not available)
Primary completion
Aug 2004 (Actual)
Completion
Aug 2004 (Actual)
Last update posted
Feb 28, 2012

2003 – 2004

United States locations

U.S. sites
51
U.S. states
28
U.S. cities
51
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Tucson Arizona — —
Not listed Bellflower California — —
Not listed Burlingame California — —
Not listed Fresno California — —
Not listed La Jolla California — —
Not listed Long Beach California — —
Not listed Pasadena California — —
Not listed Arvada Colorado — —
Not listed Norwalk Connecticut — —
Not listed Waterbury Connecticut — —
Not listed Aventura Florida — —
Not listed Hollywood Florida — —
Not listed Jacksonville Florida — —
Not listed Miami Florida — —
Not listed North Miami Beach Florida — —
Not listed Tallahassee Florida — —
Not listed West Palm Beach Florida — —
Not listed Columbus Georgia — —
Not listed Idaho Falls Idaho — —
Not listed Chicago Heights Illinois — —
Not listed Evansville Indiana — —
Not listed Des Moines Iowa — —
Not listed Lafayette Louisiana — —
Not listed Fall River Massachusetts — —
Not listed Waltham Massachusetts — —
Not listed Tupelo Mississippi — —
Not listed Chesterfield Missouri — —
Not listed Omaha Nebraska — —
Not listed Staten Island New York — —
Not listed Raleigh North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Centerville Ohio — —
Not listed Dayton Ohio — —
Not listed Medford Oregon — —
Not listed Meadville Pennsylvania — —
Not listed Pittsburgh Pennsylvania — —
Not listed Warwick Rhode Island — —
Not listed Chattanooga Tennessee — —
Not listed Morristown Tennessee — —
Not listed Murfreesboro Tennessee — —
Not listed Nashville Tennessee — —
Not listed Arlington Texas — —
Not listed Houston Texas — —
Not listed Midland Texas — —
Not listed San Antonio Texas — —
Not listed Ogden Utah — —
Not listed Orange Virginia — —
Not listed Virginia Beach Virginia — —
Not listed Man West Virginia — —
Not listed Wausau Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00672919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →